P516-0405 Screening compound: 7-FLUORO-4-OXO-N-[3-(1,2,3,4-TETRAHYDROISOQUINOLIN-2-YL)PROPYL]-4H,5H-[1,2,3]TRIAZOLO[1,5-A]QUINOXALINE-3-CARBOXAMIDE

P516-0405 Screening compound: 7-FLUORO-4-OXO-N-[3-(1,2,3,4-TETRAHYDROISOQUINOLIN-2-YL)PROPYL]-4H,5H-[1,2,3]TRIAZOLO[1,5-A]QUINOXALINE-3-CARBOXAMIDE
P516-0405 Screening compound: 7-FLUORO-4-OXO-N-[3-(1,2,3,4-TETRAHYDROISOQUINOLIN-2-YL)PROPYL]-4H,5H-[1,2,3]TRIAZOLO[1,5-A]QUINOXALINE-3-CARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound P516-0405
7-FLUORO-4-OXO-N-[3-(1,2,3,4-TETRAHYDROISOQUINOLIN-2-YL)PROPYL]-4H,5H-[1,2,3]TRIAZOLO[1,5-A]QUINOXALINE-3-CARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P516-0405

Molecular Formula

C22H21FN6O2 (C22 H21 FN6 O2)

Compound Name

7-FLUORO-4-OXO-N-[3-(1,2,3,4-TETRAHYDROISOQUINOLIN-2-YL)PROPYL]-4H,5H-[1,2,3]TRIAZOLO[1,5-A]QUINOXALINE-3-CARBOXAMIDE

IUPAC name

n/a

SMILES

O=C(c1c(C(Nc2c-3ccc(F)c2)=O)n3nn1)NCCCN(CC1)Cc2c1cccc2

InChI

InChI=1S/C22H21FN6O2/c23-16-6-7-18-17(12-16)25-22(31)20-19(26-27-29(18)20)21(30)24-9-3-10-28-11-8-14-4-1-2-5-15(14)13-28/h1-2,4-7,12H,3,8-11,13H2,(H,24,30)(H,25,31)

InChI Key

BLVRGTZHDKDGAO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27603430

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

420.45

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.120

Distribution Coefficient, logD

2.120

Water Solubility, LogSw

-3.02

Polar Surface Area

78.157

Acid Dissociation Constant (pKa)

6.69

Base Dissociation Constant (pKb)

8.52

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

27.30

P516-0405 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

Anticancer Library (62698 compounds)

Antiviral Library (67538 compounds)

SmartTM Library (51161 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P516-0405 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P516-0405?
Check Price and Availability of P516-0405, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P516-0405 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P516-0405
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P516-0405
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P516-0405 available by request